Premium
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia
Author(s) -
Styczynski Jan,
Pieters Rob,
Huismans Dieuwke R.,
Schuurhuis Gerrit J.,
Wysocki Mariusz,
Veerman Anjo J. P.
Publication year - 2000
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1046/j.1365-2141.2000.02211.x
Subject(s) - medicine , drug , in vitro , drug resistance , acute lymphocytic leukemia , immunology , lymphoblastic leukemia , pharmacology , leukemia , genetics , biology
The difference in the current cure rates between adult and childhood acute lymphoblastic leukaemia (ALL) may be caused by differences in drug resistance. Earlier studies showed that in vitro cellular drug resistance is a strong independent adverse risk factor in childhood ALL. Knowledge about cellular drug resistance in adult ALL is still limited. The present study compared the in vitro drug resistance profiles of 23 adult ALL patients with that of 395 childhood ALL patients. The lymphoblasts were tested by the MTT assay. The group of adult ALL samples was significantly more resistant to cytosine arabinoside, l ‐asparaginase, daunorubicin, dexamethasone and prednisolone. The resistance ratio (RR) was highest for prednisolone (31·7‐fold) followed by dexamethasone (6·9‐fold), l ‐asparaginase (6·1‐fold), cytosine arabinoside (2·9‐fold), daunorubicin (2·5‐fold) and vincristine (2·2‐fold). Lymphoblasts from adult patients were not more resistant to mercaptopurine, thioguanine, 4‐HOO‐ifosfamide, mitoxantrone and teniposide. There were no significant differences in drug resistance between adult T‐cell (T‐) ALL ( n = 11) and adult common/pre‐B‐cell (B‐) ALL ( n = 10). Additionally, adult T‐ALL did not differ from childhood T‐ALL ( n = 69). There were significant differences between adult common/pre‐B‐ALL and childhood common/pre‐B‐ALL ( n = 310) for prednisolone (RR = 302, P = 0·008), dexamethasone (RR = 20·9, P = 0·017) and daunorubicin (RR = 2·7, P = 0·009). Lymphoblasts from adults proved to be relatively resistant to drugs commonly used in therapy. This might contribute to the difference in outcome between children and adults with ALL.